Prevention of Venous Thromboembolism in Neurosurgery

A Metaanalysis


      Venous thromboembolism (VTE) is an important complication of neurosurgery. Current guidelines recommend pharmacologic prophylaxis in this setting with either unfractionated heparin or low-molecular-weight heparin (LMWH). We conducted a systematic review asking, “Among patients undergoing neurosurgical procedures, how safe and effective is the prophylactic use of heparin and mechanical devices?”


      We searched the medical literature to identify prospective trials reporting on VTE prevention (either mechanical or pharmacologic). The rates of VTE and bleeding were our primary end points and were pooled using a random-effects model.


      We identified 30 studies reporting on 7,779 patients. There were 18 randomized controlled trials and 12 cohort studies. The results of pooled relative risks (RRs) showed LMWH and intermittent compression devices (ICDs) to be effective in reducing the rate of deep vein thrombosis (LMWH: RR, 0.60; 95% confidence interval [CI], 0.44 to 0.81; ICD: RR, 0.41; 95% CI, 0.21 to 0.78). Similar results were seen when pooled rates from all 30 trials were analyzed. In head-to-head trials, there was no statistical difference in the rate of intracranial hemorrhage (ICH) between therapy with LMWH and nonpharmacologic methods (RR, 1.97; 95% CI, 0.64 to 6.09). The pooled rates of ICH and minor bleeding were generally higher with heparin therapy than with non–heparin-based prophylactic modalities.


      In a mixed neurosurgical population, LMWH and ICDs are both effective in the prevention of VTE. Sensitivity analyses have suggested that isolated high-risk groups, such as those with patients undergoing craniotomy for neoplasm, may benefit from a combination of prophylactic methods, suggesting the need for a more individualized approach to these patients.

      Key words


      CI (confidence interval), CS (compression stocking), DVT (deep venous thrombosis), ICD (intermittent compression device), ICH (intracranial hemorrhage), LMWH (low-molecular-weight heparin), PE (pulmonary embolism), RCT (randomized controlled trial), RR (relative risk), UFH (unfractionated heparin), VTE (venous thromboembolism)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ferree BA
        Deep venous thrombosis following lumbar laminotomy and laminectomy.
        Orthopedics. 1994; 17: 35-38
        • Rokito SE
        • Schwartz MC
        • Neuwirth MG
        Deep vein thrombosis after major reconstructive spinal surgery.
        Spine. 1996; 21: 853-858
        • Agnelli G
        Prevention of venous thromboembolism in surgical patients.
        Circulation. 2004; 110: IV4-IV12
        • Clagett GP
        • Anderson Jr, FA
        • Geerts W
        • et al.
        Prevention of venous thromboembolism.
        Chest. 1998; 114: 531S-560S
        • Danish SF
        • Burnett MG
        • Ong JG
        • et al.
        Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis.
        Neurosurgery. 2005; 56: 1286-1292
        • Geerts WH
        • Pineo GF
        • Heit JA
        • et al.
        Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
        Chest. 2004; 126: 338S-400S
        • Iorio A
        • Agnelli G
        Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.
        Arch Intern Med. 2000; 160: 2327-2332
        • Jadad AR
        • Moore RA
        • Carroll D
        • et al.
        Assessing the quality of reports of randomized clinical trials: is blinding necessary?.
        Control Clin Trials. 1996; 17: 1-12
        • Laupacis A
        • Wells G
        • Richardson WS
        • et al.
        Users' guides to the medical literature: V.
        How to use an article about prognosis: Evidence-Based Medicine Working Group: JAMA. 1994; 272: 234-237
        • DerSimonian R
        • Laird N
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Akçakaya HR
        Estimating the variance of survival rates and fecundities.
        Animal Conservation. 2002; 5: 333-336
        • Galbraith RF
        A note on graphical presentation of estimated odds ratios from several clinical trials.
        Stat Med. 1988; 7: 889-894
        • Mantel N
        • Haenszel W
        Statistical aspects of the analysis of data from retrospective studies of disease.
        J Natl Cancer Inst. 1959; 22: 719-748
        • Higgins JP
        • Thompson SG
        • Deeks JJ
        • et al.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Begg CB
        • Berlin JA
        Publication bias and dissemination of clinical research.
        J Natl Cancer Inst. 1989; 81: 107-115
        • Egger M
        • Davey Smith G
        • Schneider M
        • et al.
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ. 1997; 315: 629-634
        • Duval S
        • Tweedie R
        Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.
        Biometrics. 2000; 56: 455-463
        • Agnelli G
        • Piovella F
        • Buoncristiani P
        • et al.
        Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
        N Engl J Med. 1998; 339: 80-85
        • Dickinson LD
        • Miller LD
        • Patel CP
        • et al.
        Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors.
        Neurosurgery. 1998; 43: 1074-1081
        • Gerlach R
        • Scheuer T
        • Beck J
        • et al.
        Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study.
        Neurosurgery. 2003; 53: 1028-1034
        • Goldhaber SZ
        • Dunn K
        • Gerhard-Herman M
        • et al.
        Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis.
        Chest. 2002; 122: 1933-1937
        • Kurtoglu M
        • Yanar H
        • Bilsel Y
        • et al.
        Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin.
        World J Surg. 2004; 28: 807-811
        • Macdonald RL
        • Amidei C
        • Baron J
        • et al.
        Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy.
        Surg Neurol. 2003; 59: 363-372
        • Norwood SH
        • McAuley CE
        • Berne JD
        • et al.
        Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries.
        Arch Surg. 2002; 137: 696-701
        • Nurmohamed MT
        • van Riel AM
        • Henkens CM
        • et al.
        Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.
        Thromb Haemost. 1996; 75: 233-238
        • Paoletti C
        • Maubec E
        • Raggueneau JL
        • et al.
        Clinical tolerance of CY 216 (Fraxiparin) in the prevention of thromboembolic accidents after neurosurgery.
        Agressologie. 1989; 30: 363-366
        • Prestar FJ
        Prevention of thromboembolism complications with low molecular weight heparin in microneurosurgical lumbar intervertebral disk operations.
        Neurochirurgia (Stuttg). 1992; 35: 1-4
        • Voth D
        • Schwarz M
        • Hahn K
        • et al.
        Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.
        Neurosurg Rev. 1992; 15: 289-294
        • Barnett HG
        • Clifford JR
        • Llewellyn RC
        Safety of mini-dose heparin administration for neurosurgical patients.
        J Neurosurg. 1977; 47: 27-30
        • Bostrom S
        • Holmgren E
        • Jonsson O
        • et al.
        Post-operative thromboembolism in neurosurgery: a study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin.
        Acta Neurochir (Wien). 1986; 80: 83-89
        • Cerrato D
        • Ariano C
        • Fiacchino F
        Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients.
        J Neurosurg. 1978; 49: 378-381
        • Constantini S
        • Kanner A
        • Friedman A
        • et al.
        Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study.
        J Neurosurg. 2001; 94: 918-921
        • Frim DM
        • Barker II, FG
        • Poletti CE
        • et al.
        Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients.
        Neurosurgery. 1992; 30: 830-832
        • Gruber UF
        • Rem J
        • Meisner C
        • et al.
        Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations.
        Eur Arch Psychiatry Neurol Sci. 1984; 234: 157-161
        • Macdonald RL
        • Amidei C
        • Lin G
        • et al.
        Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
        Neurosurgery. 1999; 45: 245-251
        • Wen DY
        • Hall WA
        Complications of subcutaneous low-dose heparin therapy in neurosurgical patients.
        Surg Neurol. 1998; 50: 521-525
        • Bucci MN
        • Papadopoulos SM
        • Chen JC
        • et al.
        Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial.
        Surg Neurol. 1989; 32: 285-288
        • Bynke O
        • Hillman J
        • Lassvik C
        Does perioperative external pneumatic leg muscle compression prevent post-operative venous thrombosis in neurosurgery?.
        Acta Neurochir (Wien). 1987; 88: 46-48
        • Epstein NE
        Intermittent pneumatic compression stocking prophylaxis against deep venous thrombosis in anterior cervical spinal surgery: a prospective efficacy study in 200 patients and literature review.
        Spine. 2005; 30: 2538-2543
        • Epstein NE
        Efficacy of pneumatic compression stocking prophylaxis in the prevention of deep venous thrombosis and pulmonary embolism following 139 lumbar laminectomies with instrumented fusions.
        J Spinal Disord Tech. 2006; 19: 28-31
        • Nelson Jr, LD
        • Montgomery SP
        • Dameron Jr, TB
        • et al.
        Deep vein thrombosis in lumbar spinal fusion: a prospective study of antiembolic and pneumatic compression stockings.
        J South Orthop Assoc. 1996; 5: 181-184
        • Skillman JJ
        • Collins RE
        • Coe NP
        • et al.
        Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots.
        Surgery. 1978; 83: 354-358
        • Smith MD
        • Bressler EL
        • Lonstein JE
        • et al.
        Deep venous thrombosis and pulmonary embolism after major reconstructive operations on the spine: a prospective analysis of three hundred and seventeen patients.
        J Bone Joint Surg Am. 1994; 76: 980-985
        • Turpie AG
        • Hirsh J
        • Gent M
        • et al.
        Prevention of deep vein thrombosis in potential neurosurgical patients: a randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control.
        Arch Intern Med. 1989; 149: 679-681
        • Wautrecht J
        • Macquaire V
        • Vandesteene A
        • et al.
        Prevention of deep vein thrombosis in neurosurgical patients with brain tumors: a controlled, randomized study comparing graded compression stockings alone and with intermittent sequential compression: correlation with pre- and postoperative fibrinolysis; preliminary results.
        Int Angiol. 1996; 15: 5-10
        • Wood KB
        • Kos PB
        • Abnet JK
        • et al.
        Prevention of deep-vein thrombosis after major spinal surgery: a comparison study of external devices.
        J Spinal Disord. 1997; 10: 209-214
        • Agnelli G
        Prevention of venous thromboembolism after neurosurgery.
        Thromb Haemost. 1999; 82: 925-930
        • Lyman GH
        • Khorana AA
        • Falanga A
        • et al.
        American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
        J Clin Oncol. 2007; 25: 5490-5505
        • Lee AY
        Cancer and venous thromboembolism: prevention, treatment and survival.
        J Thromb Thrombolysis. 2008; 25: 33-36
        • Nishioka J
        • Goodin S
        Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
        J Oncol Pharm Pract. 2007; 13: 85-97
        • Ferretti G
        • Bria E
        • Giannarelli D
        • et al.
        Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?.
        Chest. 2006; 130: 1808-1816